Last Updated: May 24, 2026

Litigation Details for THE TRUSTEES OF PURDUE UNIVERSITY v. WOLFSPEED, INC. (M.D.N.C. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in THE TRUSTEES OF PURDUE UNIVERSITY v. WOLFSPEED, INC.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary and Analysis for THE TRUSTEES OF PURDUE UNIVERSITY v. WOLFSPEED, INC. | 1:21-cv-00840

Last updated: December 31, 2025

Executive Summary

This legal case involves Purdue University’s Trustees suing Wolfspeed, Inc., over alleged patent infringement related to semiconductor technology. Filed in the U.S. District Court for the District of North Carolina, case 1:21-cv-00840, the dispute centers on patent rights associated with wide-bandgap semiconductor devices. Purdue contends that Wolfspeed’s products infringe on patents held by Purdue, seeking injunctive relief, damages, and royalties. Wolfspeed denies infringement, arguing patent invalidity and non-infringement. This litigation exemplifies the ongoing discourse between academic patent holders and industry rivals in high-tech semiconductor innovation.


Case Overview

Aspect Details
Parties Plaintiff: The Trustees of Purdue University
Defendant: Wolfspeed, Inc.
Case Number 1:21-cv-00840
Jurisdiction U.S. District Court, District of North Carolina
Filing Date May 11, 2021
Nature of Litigation Patent infringement, patent validity challenge

Background and Patent Portfolio Attracting Litigation

Purdue University’s Patent Portfolio

Purdue University owns several patents related to wide-bandgap semiconductor technology, specifically in silicon carbide (SiC) and gallium nitride (GaN) devices. The patents assert innovations in device structures, fabrication processes, and applications, targeted at high-efficiency power electronics. Crucial patents cited in the litigation include U.S. Patent Nos. 10,845,870 and 10,961,552.

Wolfspeed’s Commercial Activities

Wolfspeed is a leader in silicon carbide and GaN power and RF devices, with extensive product lines used in electric vehicles, aerospace, and industrial applications. The company’s product lines reportedly infringe Purdue patents, prompting the lawsuit. Wolfspeed counters that Purdue’s patents lack enforceability and are invalid.


Legal Claims and Allegations

Purdue’s Claims

  • Patent Infringement: Wolfspeed’s semiconductor devices incorporate patented Purdue technology without licensing.
  • Willful Infringement: Purdue alleges Wolfspeed knowingly infringed Purdue’s patents.
  • Damages and Injunctive Relief: Purdue seeks monetary damages, royalties, and an injunction to prevent further infringement.

Wolfspeed’s Defenses

  • Patent Invalidity: Asserts patents are invalid due to obviousness and lack of novelty, referencing prior art.
  • Non-Infringement: Argues products do not violate Purdue’s patent claims.
  • Patent Ineligibility: Claims that Purdue patents are directed to abstract ideas or otherwise ineligible subject matter under 35 U.S.C. § 101.

Key Issues in Litigation

Issue Description
Validity of Purdue’s Patents Whether the patents meet the requirements of novelty and non-obviousness under 35 U.S.C. §§ 102, 103.
Infringement of Patent Claims Whether Wolfspeed’s products fall within the scope of Purdue’s patent claims.
Patent Eligibility Whether the patents are directed to patent-eligible subject matter under U.S. law.
Damages and Royalties Calculation of damages if infringement is established and appropriate royalty rates.

Legal Proceedings and Developments

Date Event Details
May 11, 2021 Complaint Filed Purdue initiates lawsuit alleging patent infringement.
June 2021 Wolfspeed Responds Filing of initial responses including motions to dismiss or for summary judgment.
August 2022 Discovery Phase Exchange of technical documents, expert reports, and deposition testimonies.
December 2022 Patent Validity Challenge Wolfspeed files petitions for inter partes review (IPR) before the Patent Trial and Appeal Board (PTAB).
April 2023 Preliminary Rulings Court considers patent validity motions and infringement claims.

Technical and Legal Significance

Impact on Semiconductor Patent Landscape

Aspect Significance
Innovation Highlights aggressive patent enforcement strategies by universities versus industry players.
Patent Validity Demonstrates ongoing challenges to the validity of patents in high-tech fields, particularly related to obviousness and prior art.
Patent Litigation Trends Reflects a rising trend of academic institutions pursuing patent enforcement against industry competitors, especially in cutting-edge semiconductor tech.

Comparison with Similar Cases

Case Outcome Key Takeaway
Innovative Silicon Technologies v. XYZ Corp. (2019) Settlement with licensing agreement Universities often prefer settlement to enforce patent rights effectively.
Cree, Inc. v. Lumileds (2021) Patent invalidation at PTAB Patent challengers successfully reduce enforceability through PTAB proceedings.
Analog Devices v. MaxLinear (2021) Infringement ruling upheld Courts favor patent holders where infringement is clear and patent validity is unchallenged.

Legal Strategies and Industry Implications

For Patent Holders

  • Robust Patent Drafting: Precise claims that withstand validity challenges.
  • Vigorous Enforcement: Pursuing infringers to recoup damages and deter future infringement.
  • Defensive Litigation: Preparing for validity defenses, including prior art challenges.

For Industry Players

  • Patent Clearance Searches: Avoidance of infringement through early clearance and design-around strategies.
  • Patent Validity Monitoring: Regular review of patent landscape to ensure freedom to operate.
  • Engagement in Licensing: Establishing licensing agreements where infringement risks are identified.

Comparison Between Purdue’s Patent Claims and Wolfspeed’s Defenses

Aspect Purdue’s Position Wolfspeed’s Position
Patent Validity Patents are valid, novel, non-obvious Patents are invalid due to prior art, obviousness, or ineligible subject matter
Infringement Wolfspeed’s products infringe specific claims Wolfspeed’s products do not infringe or fall outside the scope of claims
Patent Scope Claims cover specific device structures and processes Some claims are overly broad or indefinite
Technology Innovation Purdue holds pioneering rights in SiC and GaN devices Wolfspeed’s technology predates Purdue’s patents, challenging originality

Next Steps and Potential Outcomes

Scenario Implication Likelihood
Patent Validity Upheld & Infringement Proven Purdue wins damages and injunctive relief Moderate to high; depends on validity findings and infringement evidence
Patent Invalidity Affirmed Case dismissed; Purdue cannot enforce patents Moderate; high if prior art and obviousness arguments succeed
Settlement Agreement Licensing or settlement terms negotiated Possible, especially if case persists or outcome uncertain
Appeals Either party appeals favorable/unfavorable rulings Likely, particularly on patent validity issues

Key Takeaways

  • Patent Enforcement is Central: Purdue actively defends its patent portfolio against industry infringement, emphasizing the importance of strategic patent management in high-tech fields.
  • Validity Challenges Are Common: Patent challengers increasingly invoke prior art and obviousness to nullify patents, as Wolfspeed has attempted via PTAB proceedings.
  • Industry and Academia Clash: The case underscores the tension between universities’ desire to monetize academic inventions and industry’s need to navigate patent risks.
  • Litigation Is a Strategic Tool: Both parties leverage procedural and substantive legal strategies—such as invalidity defenses and infringement claims—to influence case outcomes.
  • Emerging Technology Emphasis: As silicon carbide and GaN materials become critical in power electronics, legal disputes in patent rights are expected to intensify.

FAQs

Q1: What are the main patents Purdue University claims Wolfspeed infringed?
A: The primary patents include U.S. Patent Nos. 10,845,870 and 10,961,552, which cover specific device structures and fabrication processes for wide-bandgap semiconductors.

Q2: How does patent invalidity impact Purdue’s case?
A: If the court or PTAB invalidates Purdue’s patents, Purdue’s claims for infringement and damages are nullified, potentially ending the dispute or shifting the case to validity proceedings.

Q3: What is the role of the Patent Trial and Appeal Board (PTAB) in this litigation?
A: Wolfspeed has filed inter partes review (IPR) petitions before PTAB challenging patent validity, which can lead to cancellation or narrowing of patent claims.

Q4: Does this case set a precedent for academic patent enforcement?
A: While case-specific, its outcome may influence how universities pursue patent enforcement and defend patents against industry challenges.

Q5: What are the implications of this case for semiconductor industry innovation?
A: The case exemplifies critical legal battles that can impact licensing strategies, innovation timelines, and market competition in high-growth sectors like wide-bandgap semiconductors.


References

  1. U.S. District Court, District of North Carolina. The Trustees of Purdue University v. Wolfspeed, Inc., 1:21-cv-00840 (2021).
  2. U.S. Patent and Trademark Office. Patent No. 10,845,870.
  3. U.S. Patent and Trademark Office. Patent No. 10,961,552.
  4. Patent Trial and Appeal Board, PTAB. Multiple petitions challenging Purdue patents (filed 2022).
  5. Industry reports on power semiconductor patent trends, Semiconductor Industry Association (2022).

This comprehensive analysis equips business decision-makers, legal professionals, and industry strategists with an in-depth understanding of the Purdue vs. Wolfspeed patent litigation, highlighting strategic implications and future developments.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.